Oxidative stress and functional deficit in diabetic cardiomyopathy

Advances in Experimental Medicine and Biology

Volumn 498, Issue , 2001, Pages 213-220

  Singal, Pawan K ^a   Belló Klein, Adriane ^a   Farahmand, Firoozeh ^a   Sandhawalia, Vic ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Antioxidant Enzymes; Heart Failure; Lipid Peroxidation; Probucol

Indexed keywords

ANTIOXIDANT; FREE RADICAL;

ANIMAL MODEL; ANTIOXIDANT ACTIVITY; AUTOOXIDATION; CARBOHYDRATE METABOLISM; CARDIOMYOPATHY; CONFERENCE PAPER; DIABETES MELLITUS; HUMAN; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL;

ANIMALS; CARDIOMYOPATHIES; DIABETES MELLITUS; DIABETIC ANGIOPATHIES; DISEASE MODELS, ANIMAL; FREE RADICALS; HUMANS; OXIDATIVE STRESS;

ANIMALIA;

EID: 0035703356     PISSN: 00652598     EISSN: None     Source Type: Journal    
DOI: 10.1007/978-1-4615-1321-6_27     Document Type: Article

References (57)

1. Free radicals in health and disease
2. Free radicals and the heart
3. Cellular defenses against damage from reactive oxygen species
4. Oxidants and human disease: Some new concepts
5. Superoxide dismutase. An enzymatic function for erythrocuprein (hemecuprein)
6. Hydroperoxide metabolism in mammalian tissues
7. Antioxidant enzymes and their modification under oxidative stress conditions
8. Is vitamin E the only lipid soluble, chain breaking antioxidant in human plasma and erythrocyte membranes?
9. Higher antioxidant capacity during a chronic stable heart hypertrophy
10. Role of oxidative stress in heart failure subsequent to myocardial infarction
11. Glucose auto-oxidation and protein modification. The potential role of 'autoxidative glycosylation' in diabetes
12. Nonenzymatic glycosylation of protein: Relevance to diabetes
13. Role of oxygen derived radicals for vascular dysfunction in the diabetic heart: Prevention by alpha-tocopherol?
14. Oxidative stress and diabetic vascular complications
15. The oxidation of oxyhaemoglobin by glyceraldehyde and other simple monosaccharides
16. Glycation and inactivation of human Cu-Zn-superoxide dismutase. Identification of the in vitro glycated sites
17. Nonenzymatic glycation of bovine serum albumin by fructose (fructation). Comparison with the Maillard reaction initiated by glucose
18. Aminoguanidine prevents diabetes-induced arterial wall-protein cross linking
19. Glycation of proteins as a source of superoxide
20. Introduction of apoptosis by high proinsulin and glucose in cultured human umbilical vein endothelial cells is mediated by reactive oxygen species
21. Diabetes mellitus, hypertension and cardiovascular disease: Which role for oxidative stress?
22. Oxidative stress and lipids in diabetes: A role in endothelium vasodilator dysfunction?
23. Identification of N epsilon-carboxymethyllysine as a degradation product of fructoselysine in glycated protein
24. Epsilon-amino-lysine-bound glucose in human tissues obtained at autopsy. Increase in diabetes mellitus
25. Superoxide production from nonenzymatically glycated protein
26. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins
27. Glycosylated hemoglobin in human and animal red cells. Role of glucose permeability
28. Lipid peroxide level in plasma of diabetic patients
29. Lipid peroxide levels of serum lipoprotein fractions of diabetic patients
30. Increased oxidizability of plasma lipoproteins in diabetic patients can be decreased by probucol therapy and is not due to glycation
31. Elevated levels of heat-shock protein 70 (HSP70) in the mononuclear cells of patients with non-insulin-dependent diabetes mellitus
32. Plasma ubiquinol/cholesterol ratios in patients with hyperlipidaemia, those with diabetes mellitus and in patients requiring dialysis
33. Antioxidant enzyme alterations in experimental and clinical diabetes
34. Endothelial dysfunction and pathogenesis of diabetic angiopathy
35. Reduction of oxidative tress by oral N-acetyl-L-cysteine treatment decreases plasma soluble vascular cell adhesion molecule-1 concentrations in non-obese, non-dyslipidaemic, normotensive patients with non-insulin-dependent diabetes
36. Oxidant stress-induced transendothelial migration of monocytes is linked to phosphorylation of PECAM-1
37. The role of oxidative stress in neuropathy and other diabetic complications
38. Future prevention and treatment of diabetic neuropathy
39. Neuroprotection by metabolic antioxidant alpha-lipoic acid
40. Antioxidant enzyme status and lipid peroxidation in various tissues of diabetic and starved rats
41. Alterations of antioxidant tissue defense enzymes and related metabolic parameters in streptozotocin-diabetic rats - Effects of iodine treatment
42. Lipid peroxidation, glutathione levels and changes in glutathione-related enzyme activities in streptozotocin-induced diabetic rats
43. Alterations in tissue antioxidant systems in the spontaneously diabetic (BB Wistar) rat
44. Peroxidative changes in experimental diabetes mellitus
45. Oxidative stress measurement by in vivo electron spin resonance spectroscopy in rats with streptozotocin-induced diabetes
46. Altered activities of transcription factors and their related gene expression in cardiac tissues of diabetic rats
47. Endothelial relaxation is disturbed by oxidative stress in the diabetic rat heart: Influence of tocopherol as antioxidant
48. Acute probucol treatment partially restores vasomotor activity and abnormal lipid metabolism whereas morphological changes are not affected in aorta from long-term STZ-diabetic rats
49. Insulin reversal of biochemical changes in hearts from diabetic rats
50. Biochemical and functional changes in hearts from rabbits with diabetes
51. Subcellular remodeling and heart dysfunction in chronic diabetes
52. Increased oxysterol contents in diabetic rat hearts: Their involvement in diabetic cardiomyopathy
53. Mechanisms that may be involved in calcium tolerance of the diabetic heart
54. Effects of probucol on impaired cardiac performance and lipid metabolism in streptozotocin-induced diabetic rats
55. Probucol improves antioxidant activity and modulates development of diabetic cardiomyopathy
56. Probucol treatment reverses antioxidant and functional deficit in diabetic cardiomyopathy